Overview

A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The primary aim of the study was to characterize and quantify the histopathological changes in the surgical specimens obtained in patients undergoing prostatectomy in addition to imaging changes (MRI) following a single injection of Liproca Depot in patients with localized prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Lidds AB
Collaborator:
Uppsala University
Treatments:
Flutamide
Hydroxyflutamide